×

Modulation of eIF4E-BP2 expression

  • US 7,807,652 B2
  • Filed: 11/21/2006
  • Issued: 10/05/2010
  • Est. Priority Date: 11/21/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of decreasing hepatic triglyceride levels in an animal comprising administering to said animal an antisense compound 12-80 nucleobases in length targeted to a nucleic acid molecule encoding eIF4E-BP2, wherein said compound inhibits the expression of eIF4E-BP2.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×